- May 17-20, 2026
- Philadelphia, PA | USA
Summary
At the upcoming ISPOR 2026, Evalueserve will contribute to the ongoing dialogue shaping the future of healthcare decision-making. As the industry navigates rapid scientific advancements, evolving care models, and growing demands for affordability and equity, the importance of robust, evidence-based insights has never been greater. Through its participation, Evalueserve will showcase its expertise in health economics and outcomes research (HEOR), presenting four posters across Epidemiology and Public Health, Clinical Outcomes, and Economic Evaluation. These contributions reflect the organization’s commitment to generating high-quality evidence that supports policymakers, payers, and stakeholders in making informed decisions that balance innovation with sustainable, patient-centered access.
Key Highlights
- Demonstrating AI solutions that improve underwriting, risk assessment, claims, and customer experience.
- Discussing best practices for successful AI adoption, including data governance, workflow integration, and team alignment.
- Engaging audience Q&A with insights and collaborative problem-solving.
Presenter:
Dr. Jagriti Prasad
Manager, Insights & Advisory, Life Sciences and Healthcare
Dr. Prasad is an ambitious and qualified public health professional, with deep data analytics and medical science expertise backed by experience as a dental surgeon. Dr. Prasad is trained in applied epidemiology, health economics, systematic reviewing, critical appraisal, medical writing and health services research across disease areas like oncology.
Team experts:
Coleen Hobaugh
Director for Life Sciences and Healthcare Insights and Analytics
Gabe Keeler
Vice President
Presentations:
|
Title
|
Category
|
Summary
|
Time & session details
|
Link
|
|---|---|---|---|---|
|
EPH 76: EPIDEMIOLOGY AND FUTURE BURDEN OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG ADULTS IN THE UNITED STATES: A SYSTEMATIC REVIEW
|
Epidemiology and Public Health
|
Comprehensive systematic review and projection analysis exploring the evolving epidemiology and future healthcare burden of ATTR CM to support improved screening and planning strategies.
|
May 18th 2026. Poster Session: 2
|
|
|
EPH 165: LONG-TERM PROJECTIONS OF PEDIATRIC IMMUNE THROMBOCYTOPENIA BURDEN IN THE UNITED STATES: EPIDEMIOLOGIC INSIGHTS FROM 2025 TO 2050
|
Epidemiology and Public Health
|
Systematic review and modeling which provides insights on pediatric ITP trends over the next 25 years, to guide clinical planning, research priorities, and future care strategies for children with ITP.
|
May 19th 2026. Poster Session: 4
|
|
|
CO 185: EFFICACY OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS IN REAL-WORLD SETTINGS: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
Clinical Outcomes
|
Systematic review and meta analysis examining real world treatment outcomes with sacituzumab govitecan in mTNBC, offering fresh insights that complement evidence from pivotal clinical trials.
|
May 20th 2026. Poster Session: 5
|
|
|
EE 477: ECONOMIC EVALUATION OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS: A SYSTEMATIC LITERATURE REVIEW
|
Economic Evaluation
|
Systematic review exploring the current evidence on the cost effectiveness of sacituzumab govitecan in metastatic triple negative breast cancer, offering an overview of methodological approaches used across published evaluations.
|
May 20th 2026. Poster Session: 5
|
About Evalueserve
Evalueserve is a global leader in AI-enhanced managed services, driving operational efficiency and scalability for top financial institutions. We work with the world’s largest corporate and investment banks, private markets firms, asset managers, and regional players across North America, Latin America, EMEA, MENA, and APAC.